Articles From: Royal Dutch Shell plc: Buyback of Own Shares to SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information


2014/9/29
LONDON , September 29, 2014 /PRNewswire/ -- Royal Dutch Shell plc (NYSE:RDS.A) (NYSE:RDS.B) announces that on 29 September, 2014 it purchased for cancellation 800,000 "A" Shares at a price of 2353.62 pence per share.
Sign-up for Royal Dutch Shell plc: Buyback of Own Shares investment picks
http://media.marketwire.com/attachments/201409/79045_rr2.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147669&ProfileId=051205&sourceType=1 AIRPORT CITY, ISRAEL --
Sign-up for RR Media Selected to Deliver Arsenal FC Media investment picks
2014/9/29
Ruby Tuesday, Inc. (NYSE: RT) is scheduled to report its first quarter 2015 earnings following the close of financial markets on Wednesday, October 8, 2014 and will webcast its quarterly conference call at 5:00 p.m. Eastern time that afternoon.
Sign-up for Ruby Tuesday to Report First Quarter Results on October 8, 2014 investment picks
Rudolph Technologies, Inc. (NYSE: RTEC) announced today that Michael Plisinski, vice president and general manager of the Company’s Data Analysis and Review Business Unit has been appointed executive vice president and chief operating officer (COO) effective October 1, 2014.
Sign-up for Rudolph Technologies Appoints Michael Plisinski as Chief Operating Officer investment picks
MARLBOROUGH, Mass.
Sign-up for RXi Pharmaceuticals to Present at the 13th Annual BIO Investor Forum investment picks
FIVE POINTS, Calif.
Sign-up for S&W Announces Results for the Year Ended June 30, 2014 investment picks
HIGHLIGHTS Consists of 21 independent living facilities, 100% private pay 2,850 units located in 15 states 7.14% GAAP lease yield Annual rent escalators of 4.0% in years 2 and 3, the greater of CPI and 3.5% thereafter Credit enhancement from substantial guarantor entity including fixed charge coverage and other covenants This acquisition creates a significant shift in our portfolio composition and increases our total annualized revenues by 23.0% (pro forma as of June 30, 2014): IRVINE, Calif., Sept.
Sign-up for Sabra Acquires Portfolio of 21 Independent Living Facilities in Sale/Leaseback Transaction From Affiliates of Holiday Retirement investment picks
IRVINE, Calif., Sept.
Sign-up for Sabra Health Care REIT Announces Public Offering of 6,000,000 Shares of Common Stock investment picks
IRVINE, Calif., Sept.
Sign-up for Sabra Health Care REIT Prices Public Offering of 6,000,000 Shares of Common Stock investment picks
http://media.marketwire.com/attachments/201408/271971_SAE_logo_rgb.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147840&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for SAExploration Announces Appointment of Chief Accounting Officer investment picks
MCLEAN, Va.
Sign-up for SAIC Celebrates One-Year Anniversary investment picks
Hudson’s Bay Company (TSX:HBC) and its wholly-owned subsidiary Saks Fifth Avenue announced today plans to open a full-line Saks store in San Juan, Puerto Rico.
Sign-up for Saks Fifth Avenue to Open New Store in Puerto Rico investment picks
Hawker Energy, Inc. (OTCQB:HWKR) (the “Company”) is pleased to announce it has changed its name from Sara Creek Gold Corp.
Sign-up for Sara Creek Gold Corp. Announces Name and Ticker Symbol Change to Hawker Energy, Inc. (OTCQB:HWKR) investment picks
JOHANNESBURG , September 29, 2014 /PRNewswire/ -- Today, Sasol appointed Bongani Nqwababa as Executive Director and Chief Financial Officer (CFO) of Sasol with effect from 1 March 2015 .
Sign-up for Sasol Limited: Appointment of Executive Director and Chief Financial Officer investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received ADCETRIS (brentuximab vedotin) as consolidation therapy immediately following an autologous stem cell transplantation (ASCT) lived significantly longer without disease progression compared to patients who received placebo.
Sign-up for Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for Consolidation in Post-Transplant Hodgkin Lymphoma investment picks
2014/9/29
With a new crowd-sourced menu lineup chosen by Applebee’s social fans, America’s favorite neighborhood bar and grill is searching for this season’s biggest fan.
Sign-up for Selfie for the Win: Applebee’s® Launches #FanFavoritesSweeps Campaign to Give One Fan a Trip to Phoenix investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970237001&sourceType=1 http://media3.marketwire.com/logos/20130625-serinus_logo_update_200.jpg CALGARY, ALBERTA --
Sign-up for Serinus Energy Inc.-Ukraine: Impact of New Ukrainian Banking Regulations investment picks
Senesco Technologies, Inc. doing business as Sevion Therapeutics ("Sevion" or the "Company") (OTCQB:SNTI) today reported financial results for the fiscal year ended June 30, 2014 (“Fiscal 2014”), and also provided an overview of corporate accomplishments and plans.
Sign-up for Sevion Therapeutics Reports Fiscal Year 2014 Financial Results investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of Bankrate, Inc. (“Bankrate” or the “Company”) (NYSE: RATE) securities during the period between March 1, 2013 and September 15, 2014, inclusive (the “Class Period”) and informs investors who wish to become proactively involved in the litigation that they have until November 17, 2014 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Bankrate, Inc. To Contact Brower Piven Before The November 17, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Western District of Pennsylvania on behalf of purchasers of Education Management Corporation (“EDMC” or the “Company”) (NASDAQ: EDMC) securities between August 8, 2012 and September 16, 2014, inclusive (the “Class Period”) and informs investors who wish to become proactively involved in the litigation that they have until November 18, 2014 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Education Management Corporation to Contact Brower Piven Before the November 18, 2014 Lead Plaintiff Deadline in Class Action Lawsuit investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of purchasers of PDL BioPharma, Inc. (“PDL” or the “Company”) (NASDAQ: PDLI) securities between November 6, 2013 and September 16, 2014, inclusive (the “Class Period”) and informs investors who wish to become proactively involved in the litigation that they have until November 17, 2014 to seek appointment as lead plaintiff.
Sign-up for SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In PDL BioPharma, Inc. To Contact Brower Piven Before The November 17, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Ambit Biosciences Corporation (“Ambit” or the “Company”) (Nasdaq: AMBI) relating to the proposed buyout of the Company by Daiichi Sankyo Company, Ltd.
Sign-up for SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Royal Dutch Shell plc: Buyback of Own Shares to SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices